by Clinical Neuropsychologist | Friday, August 2, 2024 | Neuroimaging
Abstract Epilepsy, affecting 0.5%-1% of the global population, presents a significant challenge with 30% of patients resistant to medical treatment. Temporal lobe epilepsy, a common cause of medically refractory epilepsy, is often caused by hippocampal sclerosis (HS)....
by Clinical Neuropsychologist | Thursday, August 1, 2024 | Neuroimaging
Abstract Background and Purpose High-resolution magnetic resonance imaging (HR-MRI) can provide valuable insights into the histopathological characteristics of moyamoya disease (MMD). However, the patterns of vessel wall contrast enhancement have not been well...
by Clinical Neuropsychologist | Monday, July 22, 2024 | Neuroimaging
Abstract Background and Purpose Early and reliable prediction of hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS) is crucial for treatment decisions and early intervention. The purpose of this study was to conduct a systematic review and...
by Clinical Neuropsychologist | Monday, July 22, 2024 | Neuroimaging
Abstract Background and Purpose The optic nerve sheath diameter (ONSD) is a commonly used estimate of intracranial pressure (ICP). The rationale behind this is that pressure changes in the cerebrospinal fluid affect the optic nerve subarachnoid space (ONSAS)...
by Clinical Neuropsychologist | Monday, July 15, 2024 | Neuroimaging
Abstract Background and Purpose Quantitative susceptibility mapping (QSM), neurite orientation dispersion and density imaging (NODDI), and the g-ratio have separately shown differences between Parkinson’s disease (PD) and healthy controls. The g-ratio has,...